FindTrial
Sign In

Clinical Characteristics of Diabetic Ketoacidosis in Children During the COVID-19 Pandemic: A Multi-Center Cross-Sectional Study

Clinical Characteristics of Diabetic Ketoacidosis in Children During the COVID-19 Pandemic: A Multi-Center Cross-Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079103
Enrollment
Unknown
Registered
2023-12-26
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Ketoacidosis in Children

Interventions

Trail group:no

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: (1) From March 2022 to November 2022, children admitted to Jilin University First Hospital with a confirmed diagnosis of diabetes and diabetic ketoacidosis, excluding those with COVID-19 infection. From December 2022 to March 2023, patients admitted to the Pediatric Intensive Care Unit (PICU) with a confirmed diagnosis of diabetes and diabetic ketoacidosis, who also tested positive for COVID-19 antigen or nucleic acid, or had a history of contact with a confirmed COVID-19 case. (2) Insulin infusion therapy was initiated only after admission.

Exclusion criteria

Exclusion criteria: ?Age 16 years. ?The child has diabetes but does not have ketoacidosis.

Design outcomes

Primary

MeasureTime frame
Incidence rate of diabetic ketoacidosis;—

Secondary

MeasureTime frame
The severity of diabetic ketoacidosis;—

Countries

China

Contacts

Public ContactLi Yumei

The First Hospital of Jilin University

ym_li@jlu.edu.cn+86 158 0430 2907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026